Hohl Benjamin
CIK 1882764
Transactions on file
52
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-21 | 2026-10-19 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 6,018 | $231.5K | +15.0% | open → |
| 2026-10-21 | 2026-10-19 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Exer. | 6,018 | $89.4K | +198.0% | open → |
| 2026-09-21 | 2026-09-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 289 | $14.9K | -14.1% | open → |
| 2026-09-21 | 2026-09-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 2,194 | $111.3K | -12.7% | open → |
| 2026-09-21 | 2026-09-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 3,535 | $176.9K | -11.6% | open → |
| 2026-09-21 | 2026-09-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Exer. | 3,982 | $59.1K | +198.0% | open → |
| 2026-08-19 | 2026-08-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 1,388 | $82.4K | -25.4% | open → |
| 2026-08-19 | 2026-08-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 4,630 | $270.2K | -24.2% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 123 | $6.6K | -17.9% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 2,638 | $140.8K | -17.1% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 2,564 | $134.1K | -15.4% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 369 | $19.0K | -14.0% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 324 | $16.2K | -11.4% | open → |
| 2026-07-21 | 2026-07-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Exer. | 1,072 | $2.7K | +1684.3% | open → |
| 2026-06-22 | 2026-06-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 1,238 | $55.4K | -1.1% | open → |
| 2026-06-22 | 2026-06-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 3,401 | $149.2K | +0.9% | open → |
| 2026-06-22 | 2026-06-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 1,379 | $59.0K | +3.4% | open → |
| 2026-06-22 | 2026-06-17 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Exer. | 6,018 | $14.9K | +1684.3% | open → |
| 2025-01-07 | 2025-01-03 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 1,000 | $2.5K | +1684.3% | open → |
| 2025-01-07 | 2025-01-03 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 1,000 | $25.0K | +76.7% | open → |
| 2025-01-07 | 2024-12-13 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 13,000 | $32.2K | +1684.3% | open → |
| 2025-01-29 | 2025-01-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-01-29 | 2025-01-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,250 | $70.2K | +105.0% | open → |
| 2025-02-07 | 2025-02-05 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 1,000 | $22.5K | +96.5% | open → |
| 2025-02-07 | 2025-02-05 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 1,000 | $2.5K | +1684.3% | open → |
| 2025-03-03 | 2025-02-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-03-03 | 2025-02-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,250 | $66.3K | +116.8% | open → |
| 2025-03-06 | 2025-03-04 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 10,000 | $24.8K | +1684.3% | open → |
| 2025-03-26 | 2025-03-24 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 1,000 | $22.5K | +96.7% | open → |
| 2025-03-26 | 2025-03-24 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 1,000 | $2.5K | +1684.3% | open → |
| 2025-03-31 | 2025-03-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-03-31 | 2025-03-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,250 | $69.3K | +107.5% | open → |
| 2025-04-30 | 2025-04-28 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 69 | $1.3K | +131.4% | open → |
| 2025-04-30 | 2025-04-28 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,181 | $59.4K | +136.9% | open → |
| 2025-04-30 | 2025-04-28 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-05-29 | 2025-05-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,250 | $52.6K | +173.5% | open → |
| 2025-05-29 | 2025-05-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-06-17 | 2025-06-13 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,000 | $7.4K | +1684.3% | open → |
| 2025-06-17 | 2025-06-13 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,000 | $67.7K | +96.2% | open → |
| 2025-12-23 | 2025-12-22 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Exer. | 13,000 | $32.2K | +1684.3% | open → |
| 2025-10-01 | 2025-09-29 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Sale | 3,250 | $66.3K | +116.9% | open → |
| 2025-10-01 | 2025-09-29 | ELVN Enliven Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-07-01 | 2025-06-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 198 | $4.3K | +104.3% | open → |
| 2025-07-01 | 2025-06-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,052 | $63.7K | +112.1% | open → |
| 2025-07-01 | 2025-06-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-07-14 | 2025-07-10 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 1,000 | $22.7K | +95.3% | open → |
| 2025-07-14 | 2025-07-10 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 1,000 | $2.5K | +1684.3% | open → |
| 2025-07-30 | 2025-07-28 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,185 | $65.1K | +116.4% | open → |
| 2025-07-30 | 2025-07-28 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 65 | $1.4K | +107.7% | open → |
| 2025-07-30 | 2025-07-28 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-08-29 | 2025-08-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Exer. | 3,250 | $8.1K | +1684.3% | open → |
| 2025-08-29 | 2025-08-27 | ELVN Enliven Therapeutics, Inc. | Officer CHIEF FINANCIAL OFFICER | Sale | 3,250 | $67.0K | +114.5% | open → |
